Merck seeks cervical cancer vaccine OK
5th Dec 2005, 18:23 GMT
Merck & Co. Inc. submitted an application with the Food and Drug Administration Monday seeking approval for Gardasil, its experimental cervical cancer vaccine.
Merck seeks cervical cancer vaccine OK related news:
- Merck seeks FDA approval for cancer vaccine — Pharmaceutical Business Review Online
- Preventive vaccine for cervical cancer — Health News
- Cancer researcher nominated for award — HEALTH
- Merck Files For Priority FDA Approval Of HPV Vaccine Gardasil — Medical News Today RSS/XML Feed
- Virus clue to cervical cancer jab — BBC News | UK | UK Edition
- Business news in brief from around New Jersey — New Jersey News
- Merck's Gardasil likely to be blockbuster — United Press International - Health Business
- Merck sends cervical cancer shot to FDA — CNNmoney.com Recently Published/Updated
- Global meeting identifies cost-effective approaches to cervical cancer prevention — EurekAlert! - Medicine and Health
- Vaccines may prevent common cervical cancer — Health News
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- Mayo to shut down drug-testing unit
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson